Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bosco & Crossy's stock picks,talk area -- Ignore unavailable to you. Want to Upgrade?

To: Steve Misic who wrote (3558)	7/11/2003 11:35:57 AM
From: Crossy	Read Replies (2) \| Respond to of 37387

Re: Positron - POSC (OTC/BB) $0.09 my stance: Strong buy, albeit speculative kudos to you Stephen for mentioning this company. After a quick scan and reply I concluded it's time to explore this one more deeply and you were right. This stock has all the ingredience for a multibagger. Thx again for the alert. Until recently there was nothing that would have attracted me on the company. Financials mentioned a negative book value as a drawback, around 63m shares out plus warrants and stagnant sales at slight losses. Price/sales always above 1 (TTM). Well that was until some months ago. In the meantime, PET technology (Positron Emission Tomography) made great progress as an accepted imaging method of great analytical use. Realtime inspection of cells' interaction and body metabolisms are unprecendeted in diagnostic imaging, thanx to the widespread diffusion of PET instruments in the diagnostic institutions. Well last quarter's statement of POSC surely reflected this underlying strength of PET deployment. The company showed a great surge in revenues to $3.8m for the last quarter and a profit. Days ago a NON-EXCLUSIVE licensing deal with GE elmininated not only a note of $2m and with it the negative equity figure of Positron, also 9m shares were redeemed and 2.5m warrants on POSC held by GE with it. The market of PET related technology makers consists of 3 US players: GE (General Electric), ALOG (Analogic) and Positiron (POSC) 2 European heavyweights with Siemens and Philips plus 2 Japanese firms with Shimadzu and another one. POSC has a particular strength in it's accompanied software offerings, which they licensed to GE on a non-exclusive basis, which I mentioned above. In addition to expanding revemnue and increased profitability, I could certainly expect Positron to do similar and if not better remunerated deals with all the other players for non-exclusive software licenses to their technology. I also checked their convertible preferred series A which they issued back in 1996. It looks harmless, certainly not a floorless, with a "deferred payment" clause (good for POSC cashflow) convertible 1:1: into common stock of POSC. To me, while not without risks, POSC looks like a great opportunity to capitalize on a new bellwether technlogy in medical imaging. thx again for mentioning this and giving me a chance to include it in the thread's portfolio CROSSY